Multimodal CT Examination in Stroke Mimics Diagnosis
Condition(s) studied
Investigational drug(s) / intervention(s)
Multimodal brain CT: Multimodal brain CT includes NCCT, CTP, and CTA
Magnetic resonance imaging (MRI): MRI examination will be performed between the 3rd and 7th day after the admission to the hospital
Study summary
The proposed project is a multicentre prospective observational clinical research focused on refining multimodal computer tomography (CT) diagnostics in stroke mimics. The main aim is to accurately identify SM in order to minimize the risk of receiving inappropriate treatment and possible development of complications, which can have a negative impact on the patient´s health. The project includes an analysis of pharmacoeconomic parameters. It will examine saved costs in the case of non-administration of unindicated treatment and it will compare the number of adverse events related to the administration of unindicated treatment in patients diagnosed with SM.
Eligibility
Primary outcome measure(s)
- The difference of patients with SM — up to 7 days
The primary objective is to demonstrate the specificity and sensitivity of multimodal brain imaging (NCCT, CTA and CTP) when compared to the use of NCCT or NCCT/CTA in the acute diagnostics of SM in patients with a sudden focal neurological deficit (minimum 1 point on the National Institutes of Health Stroke Scale - NIHSS) within 24 hours from the onset of symptoms. The difference will be measured in per cent (%)
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| University of Ostrava | Ostrava | Moravian-Silesian Region | Recruiting |
| University Hospital Ostrava | Ostrava | Moravian-Silesian Region | Recruiting |
| Hospital České Budějovice | České Budějovice | South Bohemian Region | Recruiting |
More University Hospital Ostrava trials in Czechia
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06045455 on ClinicalTrials.gov ↗ ← All trials in Czechia